Kintsugi (金継ぎ) is the traditionjal Japanese art of repairing broken pottery with lacquer or gold, with the aim to make the piece even more valuable in the end.
This is what we aim for at Repairon.
Our vision is, that EHM products will become the most valuable “gold” standard for the repair of damaged hearts and to significantly improve patient’s quality of life.
We are Repairon
Prof. Dr. Wolfram Zimmermann
Professor for Pharmacology and Director of the Institute of Pharmacology and Toxicology at the University Medical Center Göttingen (UMG) since 2008 and physician/scientist with a longstanding (> 25 years) research focus in tissue engineering and tissue engineered heart repair. Prof. Zimmermann and his team have invented several tissue engineering technologies, including the EHM technology. His leadership in the tissue engineering field is documented by having authored more than 200 publications and > 10 patents.
Dr. Lothar Germeroth
As trained biochemist and serial biotech entrepreneur,
Dr. Germeroth is responsible for the strategic planning and commercialization strategy. He holds several patents for automated manufacturing systems and has extensive expertise in founding and developing small and medium Biotechs. Dr. Germeroth was involved in several successfull exits and IPO´s (Jerini acquired by Shire; Stage acquired by Juno Therapeutics acquired by Celgene acquired by Bristol Myers Squibb, Cytos IPO) and is presently member of the management team
of Juno Therapeutics and member of the global cell therapy management team of Bristol Myers Squibb. He is involved in the development and commercialization of two CAR-T cell products for the treatment of myeloma and lymphoma and is overseeing the entire development and production process until commercialization.
Dr. Rainer Knaus
> 20 years experience as Business Unit Manager, Senior Vice President Operations, and Managing Director of various biotech companies. Successfully established manufacturing processes and GMP manufacturing facilities for various cell-based therapeutics in Germany, UK, and US. Supplied first patient-specific Stem-cell and T-cell based cellular therapeutics for commercial use in Germany and the UK.
Managing Director Business Operations
> 30 years experience in accounting including almost 20 years as an auditor (Wirtschaftsprüfer) and tax consultant (Steuerberater).
The last 8 years as Sr. Director Business Operations responsible for accounting, HR and IT in German subsidiaries of international pharmaceutical companies.
Dr. Christian Ullrich
Head of Quality / Manufacturing
> 30 years industrial experience in GMP production, GMP quality assurance and quality control with a focus on biopharmaceutical products such as recombinant proteins and advanced therapy medicinal products (ATMPs).
Dr. Nathalie Veith
Management GMP Production
> 10 years professional experience in biopharmaceutical development and manufacturing of antibodies in eukaryotic cell lines, as well as extensive experience in cell line- and process-development as well as GMP production.
Dr. Uwe Carl
Head of Technical Operations
> 25 years of experience in the life science environment, extensive knowledge in structuring R&D and production facilities and setting up QM systems. Before joining Repairon, Uwe held various positions at IBA Lifesciences (Head of Protein Production) and myriamed GmbH (Director Technical Operations).
Dr. Malte Tiburcy
Physician/scientist with a board certification in Pharmacology and Toxicology. Group leader at the Institute of Pharmacology and Toxicology at the University Medical Center Göttingen with > 10 years experience in tissue engineering. Co-inventor with Prof. Zimmermann on several key technologies licensed by Repairon.